Invention Grant
- Patent Title: Cysteine protease
-
Application No.: US17644315Application Date: 2021-12-14
-
Publication No.: US11667905B2Publication Date: 2023-06-06
- Inventor: Christian Kjellman , Sofia Jarnum , Emma Nordahl
- Applicant: Hansa BioPharma AB
- Applicant Address: SE Lund
- Assignee: HANSA BIOPHARMA AB
- Current Assignee: HANSA BIOPHARMA AB
- Current Assignee Address: SE Lund
- Agency: Norton Rose Fulbright US LLP
- Priority: GB 02306 2015.02.12
- Main IPC: C12N9/54
- IPC: C12N9/54 ; C12N9/52 ; A61K38/48 ; A61K38/00
Abstract:
The present invention relates to a novel polypeptide which displays IgG cysteine protease activity, and in vivo and ex vivo uses thereof. Uses of the polypeptide include methods for the prevention or treatment of diseases and conditions mediated by IgG, and methods for the analysis of IgG.
Public/Granted literature
- US20220170004A1 CYSTEINE PROTEASE Public/Granted day:2022-06-02
Information query
IPC分类:
